Cytokeratin, pan Antibody (AE-1/AE-3)

Images

 
Immunocytochemistry/ Immunofluorescence: Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - MCF-7 cells stained with Biotin conjugated version of pan Cytokeratin antibody and SAv-A488. A) SAv-A488 only at a dilution ...read more
Immunohistochemistry-Paraffin: Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - Pan Cytokeratin was detected in immersion fixed paraffin-embedded sections of human liver cancer tissue using 1.7 ug/mL of mouse ...read more
Flow (Intracellular): Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - An intracellular stain was performed on HeLa cells with pan Cytokeratin Antibody (AE1 + AE3) NBP2-33200R (blue) and a matched isotype control ...read more
Immunohistochemistry-Paraffin: Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - Analysis using Azide and BSA Free version of NBP2-29429. Human Colon Carcinoma stained with pan Cytokeratin Monoclonal Antibody ...read more
Flow Cytometry: Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - Human Pan-Cytokeratins on HeLa Cells. Black: Cells alone; Green: Isotype Control; Red: PE-labeled Pan-Cytokeratin Monoclonal Antibody (AE-1/AE-3)
Flow Cytometry: Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - Analysis using Azide and BSA Free version of NBP2-29429. Black: Cells alone; Green: Isotype Control; Red: PE-labeled Pan-Cytokeratin Monoclonal ...read more
Flow Cytometry: Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - Using the PE direct conjugate An intracellular stain was performed on HT-29 cells with pan Cytokeratin (AE1 + AE3) antibody NBP2-33200PE (blue) and a ...read more
Flow (Intracellular): Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - An intracellular stain was performed on HeLa cells with pan Cytokeratin Antibody (AE1 + AE3) NBP2-33200AF647 (blue) and a matched isotype ...read more
Flow (Intracellular): Cytokeratin, pan Antibody (AE1 + AE3) [NBP2-29429] - An intracellular stain was performed on HeLa cells with pan Cytokeratin Antibody (AE1 + AE3) NBP2-33200PE (blue) and a matched isotype control ...read more

Product Details

Summary
Reactivity Hu, Mu, Rt, Bv, Ca, Ch, Pm, Rb, ReSpecies Glossary
Applications WB, Flow, Flow-IC, ICC/IF, IHC-Fr, IHC-P, Single Cell Western
Clone
AE-1/AE-3
Clonality
Monoclonal
Host
Mouse
Conjugate
Unconjugated
Concentration
0.2 mg/ml

Order Details

Cytokeratin, pan Antibody (AE-1/AE-3) Summary

Immunogen
Total keratin isolated from human epidermal callus was used as immunogen to generate the pan cytokeratin antibodies AE1 + AE3 (Woodcock-Mitchell, 1982).
Localization
Cytoplasmic
Marker
Epithelial marker
Specificity
Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI <5.7) and basic (pI >6.0) subfamilies. This antibody cocktail recognizes acidic (Type I or LMW) and basic (Type II or HMW) cytokeratins, which include CK1, CK3, CK4, CK5, CK6, CK8, CK10, CK14, CK15, CK16, and CK19. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. AE-1/AE-3 is a broad spectrum anti pan-cytokeratin antibody cocktail, which differentiates epithelial tumors from non-epithelial tumors e.g. squamous vs. adenocarcinoma of the lung, liver carcinoma, breast cancer, and esophageal cancer. It has been used to characterize the source of various neoplasms and to study the distribution of cytokeratin containing cells in epithelia during normal development and during the development of epithelial neoplasms. This antibody stains cytokeratins present in normal and abnormal human tissues and has shown high sensitivity in the recognition of epithelial cells and carcinomas.
Isotype
IgG1 Kappa
Clonality
Monoclonal
Host
Mouse
Gene
KRT1
Purity
Protein A or G purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Applications/Dilutions

Dilutions
  • Western Blot 0.5-1ug/ml
  • Flow Cytometry 0.5-1ug/million cells
  • Immunocytochemistry/Immunofluorescence 1-2ug/ml
  • Immunohistochemistry-Frozen 0.5-1.0ug/ml
  • Immunohistochemistry-Paraffin 0.5-1.0ug/ml
  • Flow (Intracellular)
  • Single Cell Western 1:10
Application Notes
Mol. Weight of Antigen: 40 - 67 kDa
1. The staining pattern of the pan cytokeratin antibody cocktail may be different than that of either antibody separately.
2. The pan cytokeratin cocktail does not react with keratin18, which is also expressed in carcinomas. As such, negative staining with NBP2-29429 in of itself may not be sufficient evidence to rule out the possibility of a carcinoma (Ordonez, 2013).
a. For example, hepatocellular, adrenal cortical, clear cell renal and chromophobe renal cell carcinomas have been reported to be negative for the pan cytokeratin antibody. In this regard, the pan cytokeratin antibody can be used as part of a screening panel to more extensively define the tumor cell lineages.
3. The pan cytokeratin antibody may cross-react with GFAP, leading to aberrant positive staining of glial tumors such as ependymoma, glioblastoma, or schwannoma (Ordonez, 2013).
Publications
Read Publications using
NBP2-29429 in the following applications:

  • ICC
    1 publication
  • 4 publications
  • IHC
    1 publication
  • 5 publications
  • WB
    2 publications

Reactivity Notes

Reptile reactivity reported in scientific literature (PMID: 11351328).

Packaging, Storage & Formulations

Storage
Store at 4C.
Buffer
10mM PBS and 0.05% BSA
Preservative
0.05% Sodium Azide
Concentration
0.2 mg/ml
Purity
Protein A or G purified

Background

Keratin/cytokeratin AE1 + AE3 is a pan cytokeratin (also known as pan keratin) antibody cocktail that detects cytokeratins 1-8, 10, 14-16 and 19 (reviewed in Ordonez, 2013). The cocktail is an optimized mixture of two different monoclonal antibody clones, AE1 and AE3. Each clone detects a subset of high and low molecular weight cytokeratins: AE1 detects 10, 14-16, and 19; AE3 detects 1-8. A key advantage of the pan cytokeratin antibody cocktail stain is that a broader spectrum of cytokeratins can be detected compared to using each clone alone.
The pan cytokeratin antibody cocktail is a well known broad spectrum immunohistochemical epithelial marker for screening for epithelial differentiation in tumors and their metastases. Most carcinomas have been reported to stain positive, and the antibody can help confirm or rule out the epithelial nature of a poorly differentiated tumor. Positive pan cytokeratin staining with the antibody in the lymph node (Nikura, 2007) or bone marrow ((Berg, 2007) can be an indication of metastatic carcinoma. The pan cytokeratin antibody has also been used to identify residual tumor post-treatment (Azumi, 2006), assess the depth of cancerous invasion (Alexander-Sefre, 2004) and predict survival outcome (Wiedswang, 2004).
Negative pan cytokeratin staining patterns can suggest non-epithelial components associated with a carcinoma. For example, ductal lavage foam cells from breast carcinoma patients did not stain with the antibody (Krishnamurthy, 2002). Foam cells are apparently of macrophage origin and hence pan cytokeratin cocktail negative.
The pan cytokeratin antibody staining patterns have been extensively documented in epithelium and numerous tumor types, dating back to 1982 (Woodcock-Mitchell) when the clones were first developed. As such, researchers are encouraged to survey the published literature for additional information about pan cytokeratin positive and negative staining tumors as well as in normal tissue.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

NBP2-61736
Species: Hu, Mu, Rt, Mk
Applications: WB, ELISA, Flow, IHC, IHC-P
NBP2-34270
Species: Hu, Mu, Rt
Applications: WB, Simple Western, Flow, ICC/IF, IHC-Fr, IHC-P, IP
NBP2-22194
Species: Hu, Mu, Mk
Applications: WB, ELISA, Flow, ICC/IF, IHC, IHC-P, CyTOF-ready
NB100-2727
Species: Hu, Po, Ca, Pm
Applications: WB, Flow, ICC/IF, IHC, IHC-P, IP, CyTOF-ready
NBP1-87528
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P
NBP1-84730
Species: Hu
Applications: WB, ICC/IF, IHC, IHC-P
NBP2-34844
Species: Hu, Mu, Bv, Rb
Applications: WB, IHC-Fr, IHC-P
NBP2-67727
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
NBP2-38166
Species: Hu
Applications: WB, ICC/IF, IHC, IHC-P
NBP2-67559
Species: Hu
Applications: WB, Flow, ICC/IF, IHC, IHC-P
NBP1-85630
Species: Hu
Applications: WB, IHC, IHC-P
NBP1-85632
Species: Hu
Applications: ICC/IF, IHC, IHC-P
NB100-687
Species: Hu, Mu, Rt
Applications: WB, Simple Western, Flow, ICC/IF, IHC, IHC-P
NB600-41532
Species: Mu
Applications: WB, ELISA, ICC/IF, IHC, IHC-P
NBP1-33610
Species: Hu, Mu
Applications: WB, Simple Western, ICC/IF, IHC, IHC-P
NBP2-16094
Species: Hu, Mu
Applications: WB, ICC/IF, IHC, IHC-P, KO
NBP2-14144
Species: Hu
Applications: WB, IHC, IHC-P
NBP1-87709
Species: Hu
Applications: IHC, IHC-P

Publications for Cytokeratin, pan Antibody (NBP2-29429)(15)

We have publications tested in 4 confirmed species: Human, Canine, Lizards, Zebrafish.

We have publications tested in 5 applications: ICC, ICC/IF, IHC, IHC-P, WB.


Filter By Application
ICC
(1)
ICC/IF
(4)
IHC
(1)
IHC-P
(5)
WB
(2)
All Applications
Filter By Species
Human
(4)
Canine
(1)
Lizards
(1)
Zebrafish
(1)
All Species
Showing Publications 1 - 10 of 15. Show All 15 Publications.
Publications using NBP2-29429 Applications Species
Oppel F, Tao T, Shi H et al. Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies. PLoS Genet. 2019 Apr 10 [PMID: 30970016] (IHC-P, Zebrafish)

Details:
Citation using the Azide and BSA Free form of this antibody.
IHC-P Zebrafish
Wan J, Block S, Scribano CM et al. Mad1 destabilizes p53 by preventing PML from sequestering MDM2. Nat Commun. 2019 Apr 4 [PMID: 30948704] (IHC-P, Human)

Details:
Citation using the Azide and BSA Free form of this antibody.
IHC-P Human
Jensen T, Wanczyk H, Sharma I et al. Polyurethane scaffolds seeded with autologous cells can regenerate long esophageal gaps: An esophageal atresia treatment model. J Pediatr Surg.  2018 Oct 22 [PMID: 30429066] (ICC/IF)

Details:
Citation using the Azide and BSA Free form of this antibody.
ICC/IF
Ijsselsteijn ME, Brouwer TP, Abdulrahman Z et al. Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification. J Pathol Clin Res. 2018 Dec 4 [PMID: 30191683] (ICC/IF, Human)

Details:
Citation using the Alexa Fluor 647 form of this antibody.
ICC/IF Human
Cho CJ, Kang HJ, Ryu YM et al. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype. Gastric Cancer Apr 7 2018 [PMID: 29627937] (Human) Human
Banco B, Ferrari R, Stefanello D et al. Ovarian Embryonal Carcinoma in a Dog J. Comp. Pathol. 2017 Nov 01 [PMID: 29169625] (IHC, Canine) IHC Canine
Ordonez NG. Broad-spectrum immunohistochemical epithelial markers: a review. Hum Pathol. 2013 Jul [PMID: 23427873] (IHC-P)

Details:
IHC (P): Table 1
IHC-P
Niikura H, Okamoto S, Yoshinaga K et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol. 2007 Jun [PMID: 17442382] (IHC-P)

Details:
IHC (paraffin): Fig 1 & Table 2 (lymph nodes from endometrial cancer and other patients).
IHC-P
Berg A, Berner A, Lilleby W et al. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy. Int J Cancer. 2007 Apr 15 [PMID: 17230512] (ICC/IF)

Details:
ICC: Figs 1-3, Tables II-IV (bone marrow cytospins from prostate cancer patients).
ICC/IF
Azumi M, Saga Y, Hashimoto H et al. [Histological investigation of prostate cancer treated with hormonal agents]. Hinyokika Kiyo. 2006 Oct [PMID: 17131867]

Details:
Prostate specimens, see publication for details.
Show All 15 Publications.

Reviews for Cytokeratin, pan Antibody (NBP2-29429) (0)

There are no reviews for Cytokeratin, pan Antibody (NBP2-29429). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Video Protocols

WB Video Protocol
ICC/IF Video Protocol

FAQs for Cytokeratin, pan Antibody (NBP2-29429). (Showing 1 - 1 of 1 FAQs).

  1. Could you tell us recommended antigen retrieval method for this antibody?-EndFragment-->
    • Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes. Optimal dilution of antibody for IHC should be determined by the user. 

Secondary Antibodies

 

Isotype Controls

Additional Cytokeratin, pan Products

Array NBP2-29429

Bioinformatics Tool for Cytokeratin, pan Antibody (NBP2-29429)

Discover related pathways, diseases and genes to Cytokeratin, pan Antibody (NBP2-29429). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Diseases for Cytokeratin, pan Antibody (NBP2-29429)

Discover more about diseases related to Cytokeratin, pan Antibody (NBP2-29429).
 

Pathways for Cytokeratin, pan Antibody (NBP2-29429)

View related products by pathway.

PTMs for Cytokeratin, pan Antibody (NBP2-29429)

Learn more about PTMs related to Cytokeratin, pan Antibody (NBP2-29429).
 

Research Areas for Cytokeratin, pan Antibody (NBP2-29429)

Find related products by research area.

Blogs on Cytokeratin, pan

There are no specific blogs for Cytokeratin, pan, but you can read our latest blog posts.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Cytokeratin, pan Antibody (AE-1/AE-3) and receive a gift card or discount.

Bioinformatics

Gene Symbol KRT1